Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

UBS
Merck
Cipla
McKinsey
Argus Health
Julphar

Generated: September 20, 2019

DrugPatentWatch Database Preview

Litigation Details for ASTRAZENECA AB v. TORRENT PHARMA INC. (D.N.J. 2015)

  Try a free trial


See Plans and Pricing

« Back to Dashboard

ASTRAZENECA AB v. TORRENT PHARMA INC. (D.N.J. 2015)

Docket   Try a Free Trial Date Filed 2015-05-15
Court District Court, D. New Jersey Date Terminated 2018-06-13
Cause 35:271 Patent Infringement Assigned To Freda L. Wolfson
Jury Demand None Referred To Douglas E. Arpert
Parties APOTEX CORP.; APOTEX INC.; ASTRAZENECA AB; ASTRAZENECA PHARMACEUTICALS LP; ASTRAZENECA UK LIMITED; BRECKENRIDGE PHARMACEUTICAL, INC.; CERTAIN CONSOLIDATED ROFLUMILAST CASES; CITRON PHARMA LLC; HETERO LABS LIMITED; HETERO LABS LIMITED UNIT-III; HETERO USA INC.; HETERO USA, INC.; MICRO LABS LTD.; MICRO LABS USA, INC.; MSN LABORATORIES PRIVATE LIMITED; MYLAN PHARMACEUTICALS INC.; PRINSTON PHARMACEUTICAL, INC.; STRIDES PHARMA GLOBAL PTE LIMITED; STRIDES PHARMA, INC.; TAKEDA GMBH; TORRENT PHARMA INC.; TORRENT PHARMACEUTICALS LTD.; ZYDUS PHARMACEUTICALS (USA), INC.
Patents 5,712,298; 8,431,154; 8,536,206; 8,604,064; 8,618,142
Attorneys ALLISON LINDA HOLLOWS; ANDREA LYNN WAYDA; ANDREW J. MILLER; APOTEX CORP.; APOTEX INC.; ARNOLD B. CALMANN; CHRISTINA LYNN SAVERIANO; DENNIES VARUGHESE; ELISSA J. GLASBAND; ERIC I. ABRAHAM; GERI L. ALBIN; GREGORY D. MILLER; GUILLERMO CARLO ARTILES; HUA HOWARD WANG; JEFFREY S. SOOS; JENNA Z. GABAY; JOHN EDMUND FLAHERTY; KAI WENDELL MARSHALL-OTTO; KAREN A. CONFOY; MELISSA E. FLAX; MICHAEL CROSS; MICHAEL H. IMBACUAN; MICRO LABS LTD.; MICRO LABS USA, INC.; NANCY ANN DEL PIZZO; RAVIN R. PATEL; REBEKAH R. CONROY; ROBERT JOSEPH FETTWEIS; SAIRA BANO HAIDER; STEVEN JAMES LINK
Firms Axinn, Veltrop & Harkrider LLP; Budd Larner PC; Budd Larner, Pc; Carella, Byrne, Cecchi, Olstein, Brody & Agnello, P.C.; Carella, Byrne, Cecchi, Olstein, Brody & Agnello, PC; Christina Lynn Saveriano; Eric I. Abraham; Fleming Ruvoldt PLLC; Fox Rothschild LLP; Fox Rothschild LLP, Pc; McCarter and English, LLP; Office of the Attorney General, R.J. Hughes Justice Complex; Rivkin Radler LLP; Sills,Cummis & Gross P.C.; Sterne Kessler Goldstein & Fox; Stone Conroy LLC
Link to Docket External link to docket
Small Molecule Drugs cited in ASTRAZENECA AB v. TORRENT PHARMA INC.
The small molecule drug covered by the patents cited in this case is   Try a Free Trial .

Details for ASTRAZENECA AB v. TORRENT PHARMA INC. (D.N.J. 2015)

Date Filed Document No. Description Snippet Link To Document
2016-07-13 106 term "roflumilast" as it appears in U.S. Patent Nos. 8,536,206, 8,604,064, and 8,618,142, means "N-(3,5…2015 13 June 2018 3:15-cv-03375 830 Patent None District Court, D. New Jersey External link to document
2016-10-18 134 three of the patents involved in this action: U.S. Patent Nos. 8,536,206 (the “‘206 Patent”), 8,604,064…roflumilast. ‘206 Patent at 1:1-17; ‘064 Patent at 1:1-19; ‘142 Patent at 1:1-19; ‘791 Patent at 8:29-20:…roflumilast. ‘206 Patent at 1:4-9; ‘064 Patent at 1:4-13; ‘142 Patent at 1:4-13; ‘791 Patent at 8:29-20:6… ‘791 Patent on November 26, 2008. 206 Patent at 1:4-9; ‘064 Patent at 1:4-13; ‘142 Patent at 1:4-13…8,604,064 (the “‘064 Patent”), and 8,618,142 (the “‘142 Patent”) (collectively, the “Patents-at-Issue”). The External link to document
2017-06-02 181 difluoromethoxybenzamide” in U.S. Patent Nos. 8,536,206 (the “‘206 Patent”), 8,604,064 (the “‘064 Patent”), and 8,618,142…roflumilast. ‘206 Patent at 1:1-17; ‘064 Patent at 1:1-19; ‘142 Patent at 1:1-19; ‘791 Patent at 8:29-20:6…206 Patent at 8:21-10:34; ‘064 Patent at 8:37-10:33; ‘142 Patent at 8:22-9:21. 3 The ‘791 Patent, not…the same family of patents as U.S. Patent No. 7,470,791 (the “‘791 Patent”), which purportedly protects…:6. Both the ‘206 Patent and the ‘064 Patent are process patents that claim methods for the treatment External link to document
2017-08-31 192 named inventor of another asserted patent (U.S. Patent No. 5,712,298), and that none of the named inventors…respect to U.S. Patent Nos. 8, 536, 206 (“the ‘206 patent”), 8, 504, 064 (“the ‘064 patent”) and 8, 618,…618, 142 (“the ‘142 patent”) (collectively, “the Patents”) in order to assert invalidity under 35 U.S.C…contention that the Patents “were secured through extensive fraud at the U.S. Patent and Trademark Office…allege unenforceability of three of the asserted patents for inequitable conduct. Plaintiffs have filed External link to document
2017-09-01 193 MOTION for Partial Summary Judgment that US Patent No. 5,712,298 is Infringed and Not Invalid by All Plaintiffs…' Motion for Partial Summary Judgment that '298 Patent is Infringed and Not Invalid, # 3 Declaration Declaration…2015 13 June 2018 3:15-cv-03375 830 Patent None District Court, D. New Jersey External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Deloitte
Daiichi Sankyo
Cipla
Healthtrust
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.